This is a preview of subscription content, log in via an institution to check access.
References
Arendt Th, Marcova L, Bigl V, Brückner MK (1995a) Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. J Comp Neurol 351: 169–246
Arendt Th, Brückner MK, Pagliusi S, Krell T (1995b) Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury. Neuroscience 65: 633–659
Arendt Th, Holzer M, Groβmann A, Zedlick D, Brückner MK (1995c) Increased expression and subcellular translocation of the mitogen-activated protein kinase and mitogenactivated protein kinase in Alzheimer's disease. Neuroscience 68: 5–18
Arendt Th, Holzer M, Fruth R, Brückner MK, Gärtner U (1995d) PHF-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69: 691–698
Gärtner U, Holzer M, Arendt Th (1995) Induction of p21ras in Alzheimer pathology. Neuroreport 6: 1313–1316
Holzer M, Holzapfel H-P, Zedlick D, Brückner MK, Arendt Th (1995) Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63: 499–516
References 1 Published abstracts of lectures
Kalus P, Senitz D, Beckmann H (1995) Parvalbumin immunoarchitecture of the human cingulate and orbitofrontal cortex: distinct regional distribution pattern of interneurons. Clin Neuropathol 14: 265
Kalus P, Senitz D, Beckmann H (1995) Calcium-binding protein parvalbumin characterizes morphologically heterogeneous classes of local circuit neurons in the human anterior cingulate cortex. J Neural Transm 102: XXV (Abstract)
Senitz D, Jakob H, Beckmann H (1995) Structural brain malformations in the entorhinal and orbitofrontal cortex in schizophrenics. Clin Neuropathol 14: 285
Kalus P, Senitz D, Supprian T, Beckmann H (1996) Cajal-Retzius cells in schizophrenic orbitofrontal cortex. X. World Congress of Psychiatry Madrid, vol 2, p 106
Kalus P, Senitz D, Beckmann H (1996) Immuncytochemische Untersuchungen von Cajal-Retzius-Zellen bei Schizophrenen. Fortschr Neurol Psychiatr 64: 52
Senitz D, Kalus P, Beckmann H (1996) Zur morpho-funktionellen Organisation des Präfrontalcortex bei Schizophrenen. Fortschr Neurol Psychiatr 64: 52
Kalus P, Senitz D, Beckmann H (1996) Cartridge synapses of human chandelier cells and their changes in schizophrenia. 25. Neurobiologentagung, Göttingen. Thieme, Stuttgart
Publications of lectures
Kalus P, Senitz D (1996) Parvalbumin in the human anterior cingulate cortex: morphological heterogeneity of inhibitory interneurons. Brain Res 729: 45–54
Lauer M, Beckmann H (1996) The human striatum in schizophrenia. I. Increased in overall relative striatal volume in schizophrenics. Psychiatry Res Neuroimaging Sect 68: 87–98
Beckmann H, Lauer M (1996) The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics. Psychiatry Res Neuroimaging Sect 68: 99–109
Kalus P, Senitz D, Beckmann H (1997) Cortical layer I changes in schizophrenia: a marker for impaired brain development? J Neural Transm 104: 549–559
Kalus P, Senitz D, Beckmann H (1997) Altered distribution of parvalbumin-immunreactive local circuit neurons in anterior cingulate of schizophrenic patients. Psychiatry Res Neuroimaging Sect 75: 49–59
Senitz D, Kalus P, Beckmann H (1998) Some new findings in the rostral entorhinal cortex of schizophrenics. Neuroreport (in press)
Completed literature
Arnold SE, Hyman BT, van Hoesen GW, Damasio AR (1991) Some cytoarchitectural abnormities of entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48: 625–632
Arnold SE, Franz BR, Gur RC, Shapiro RM, Moberg PJ, Trojanowski JQ (1995) Smaller neurones size in schizophrenia in hippocampal subfield that mediate cortical-hippo-campal interactions. Am J Psychiatry 152: 738–748
Beckmann H, Jakob H (1991) Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychosis? J Neural Transm 84: 155–164
Beckmann H, Jakob H (1994) Pränatale Entwicklungsstörungen von Hirnstrukturen bei schizophrenen Psychosen. Nervenarzt 65: 454–463
Casanova MF, Saunders R, Althuler L, Goldberg T, Amstrong E, Kleinman JE (1991) Entorhinal cortex pathology in schizophrenia and affective disorders. In: Racagni G, Brunello N, Fukuda T (eds) Biological psychiatry. Elsevier, Amsterdam, pp 504–506
Jakob H, Beckmann H (1984) Clinical-neuropathological studies of developmental disorders in the limbic system in chronic schizophrenia. In: Schizophrenia: an integrative view. XIV. Congress CINP. Ricera Educazione Permanente [Suppl] 39: 81
Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303–326
Jakob H, Beckmann H (1994) Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. J Neural Transm 98: 83–106
Kikinis R, Shenton ME, Gerig G, Hokama H, Haimson J, O'Donnell BF, Wibble CG, McCarley RW, Jolesz FA (1994) Temporal lobe sulco-gyral pattern anomalies in schizophrenia: an in vivo MR three-dimensional surface rendering study. Neurosci Lett 182: 7–12
References
Arnold SE, Hyman BT, van Hoesen GW, Damasio AR (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48: 625–632
Beckmann H, Jakob H (1991) Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? J Neural Transm [Gen Sect] 84: 155–164
Brockhaus H (1938) Zur normalen und pathologischen Anatomie des Mandelkerngebietes (Subzona semicorticalis amygdalea und Subzona claustralis praeamygdalea). J Psychol Neurol (Lpz) 49: 1–136
Brockhaus H (1940) Die Cyto- und Myeloarchitektonik des Cortex claustralis und des Claustrum beim Menschen. J Psychol Neurol (Lpz) 49: 249–348
Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303–326
Jakob H, Beckmann H (1994) Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics — pathogenetic and clinical aspects. J Neural Transm [Gen Sect] 98: 83–106
References
Morino P, Mascagni F, McDonald A, Hökfelt T (1994) Chloecystokinin corticostriatal pathway in the rat: evidence for bilateral origin from medial prefrontal cortical areas. Neuroscience 4: 939–952
Pettersson E, Herrera-Marschitz M, Rodrigues-Puertas R, Xu Z-Q, You Z-B, Hughers J, Elde RP, Ungerstedt U, Hökfelt T (1996) Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor. Neuroscience 74: 51–66
Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P (1993) Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proc Natl Acad Sci USA 90: 11277–11281
You Z-B, Herrera-Marschitz M, Pettersson E, Nylander I, Goiny M, Shou H-Z, Kehr J, Godukhin O, Hökfelt T, Terenius L, Ungerstedt U (1996) Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. Neuroscience 74: 793–804
References
Leszek J, Gasiorowski K (1996) Therapeutic efficacy of cyclophosphamide in Alzheimer's research. 2: 43–46
Leszek J, Gasiorowski K (1996) The proposed new strategy of Alzheimer's disease immunotherapy. Med Hypothesis (in press)
Leszek J, Dobrzariska I, Gasiorowski K (1993) Alzheimer's disease immunological aspects. Acta Neurobiol Exp 53: 351–355
Leszek J, Gasiorowski K, Tołpa S, Kukla S (1993) Peat extract (PTT) treatment of Alzheimer's disease — preliminary study. Eur J Psychiatry 7/2: 69–72
Leszek J, Ślesak B, Kowal-Gierczak B, Harłozińska-Szmyrka A, Wasik A (1994) Immunosuppressive treatment of Alzheimer's disease patients with immunological defect of cells nature. Eur J Psychiatry 8/1: 15–23
Leszek J, Kiejna A, Jańczak G, Wojtowicz B, Panaszek B, Miskiewicz J (1997) Pupil reaction to Tropicamide in Alzheimer's disease — a noninvasive useful clinical test. Worlds Congress of Biological Psychiatry, Nice, June 22–27, 1997
Leszek J, Inglot AD, Janusz M, Lisowski J (1997) Colostrinine: a proline-rich polypeptide isolated from ovine colostrum, for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Biol Psychiatry (in press)
Some resultant publications
Beasley CL, Reynolds GP (1997) Parvalbumin-immunoreactive neurons are reduced in the frontal cortex of schizophrenics. Schizophr Res (in press)
Reynolds GP (1995) Neurotransmitter systems in schizophrenia. Int Rev Neurobiol 38: 305–339
Reynolds GP, Mason SL (1995) Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. Eur J Pharmacol 281: R5-R6
Reynolds GP, Sardar AM (1996) 5-Hydroxytryptamine deficits in the caudate nucleus in AIDS (letter). AIDS 10: 1303–1304
Riederer P, Gsell W, Calza L, Franzek E, Jungkunz G, Jellinger K, Reynolds GP, Crow T, Cruz-Sanchez FF, Beckmann H (1995) Consensus on minimal criteria of clinical and pathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I). J Neural Transm 102: 255–264
Sardar AM, Reynolds GP (1995) Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1 associated dementia. Neurosci Lett 186: 1–4
Sardar AM, Bell JE, Reynolds GP (1995) Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1 positive patients. J Neurochem 64: 932–935
Sardar AM, Czudek C, Reynolds GP (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910–912
Publications arising
Fitzgerald D, Anderson MC, Lawlor B, Tipton KF (1995) Substrate specificity of human platelet monoamine oxidase B in Parkinson's and Alzheimer's diseases. J Neural Transm [Gen Sect] 102: xiv-xv
Glinka Y, Tipton KF, Youdim MBH (1995) The nature of the inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J Neural Transm [Gen Sect] 102: xvi-xvii
McBean GJ, Doorty KB, Tipton KF, Kollegger H (1995) Alterations in the glial cell metabolism of glutamate by kainate and N-methyl-D-aspartate. Toxicon 33: 569–576
Tipton KF (1995) Might environmental factors contribute to neurodegenerative diseases? Biochem Soc Trans 23: 429–434
Tipton KF, McBean GJ, Davey GP (1995) Neurotoxins and neurodegenerative diseases. J Neurochem 65 [Suppl]: S65
O'Sullivan PE, Tipton KF (1996) Nicotinamide derivatives and mitochondria. Biochem Soc Trans 24: 61S
O'Byrne MB, Tipton KF, McBean G (1996) Neurotoxicity of MPP+ as studied in a tissue slice system. Biochem Soc Trans 24: 62S
Glinka Y, Tipton KF, Youdim MBH (1996) The nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J Neurochem 66: 2004–2010
Davey G, Tipton KF (1996) Chronic ethanol consumption and mitochondrial sensitivity to 1-methyl-4-phenylpyridinium (MPP+) inhibition. Biogen Amines 12: 103–115
Tipton KF, Naoi M, Parvez SH, Nagatsu T (eds) (1996) Naturally occurring xenobiotic toxins and neurodegenerative disorders. Biogen Amines 12: 1–190
Tipton KF (1996) Possible mechanisms of neuroprotection in response to diverse insult. J Neurochem 66 [Suppl 2]: S20A
O'Byrne MB, Bolam JP, Tipton KF (1996) The neurotoxic effects of 1-methyl-4-phenylpyridinium and potential neuroprotection by taurine. 2nd Meeting of European Neuroscience, Strasbourg, France, p 216 (Abstract)
O'Byrne MB, Tipton KF, McBean G, Kollegger H (1997) Assessment of neurotoxicity and “neuroprotection”. J Neural Transm [Suppl] 50: 153–164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arendt, T., Bigl, V., Beckmann, H. et al. Abstracts. J. Neural Transmission 104, 1127–1166 (1997). https://doi.org/10.1007/BF01273325
Issue Date:
DOI: https://doi.org/10.1007/BF01273325